scMRdb: a comprehensive resource for cell-type-resolved Mendelian randomization of complex traits
Nucleic Acids Research · 29.10.2026
DOI: 10.1093/nar/gkag1063 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 29.10.2026. Verfasst von Siyu Pan und 2 weiteren Autor:innen. Beteiligte Einrichtung: China National Center for Bioinformation, Beijing 100101, China. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: the National Science and Technology Major Project, Strategic Priority Research Program of the Chinese Academy of Sciences, National Natural Science Foundation of China.
Abstract (Originalsprache)
Mendelian randomization (MR) is a powerful analytical approach to infer putative causal links between gene expression and human disease, using genetic variants as instrumental variables to mitigate confounding and reverse causation. However, existing MR resources predominantly rely on bulk-tissue expression quantitative trait loci (eQTLs), which mask cell-type-specific transcriptional effects by averaging expression across cellular populations. Furthermore, cell-type-resolved causal evidence from single-cell eQTL (sc-eQTL) MR analyses remains fragmented across individual studies with inconsistent workflows, prohibiting standardized cross-cell-type comparisons. Here we present scMRdb (https://ngdc.cncb.ac.cn/scmrdb), a comprehensive resource for cell-type-resolved MR of human complex traits and diseases. scMRdb harmonizes 5206 genome-wide association study (GWAS) summary statistics of European and East Asian ancestry with 585 sc-eQTL datasets spanning 11 tissues and cell systems, including 110 cell types. A uniform pipeline evaluates all gene–trait pairs via MR followed by Steiger directionality testing. Significant associations are assessed by colocalization, and results are stratified into six confidence tiers with integrated drug–target annotation. scMRdb enables systematic recovery of candidate causal genes supported by cell-type-resolved regulatory evidence that is often diluted or obscured in bulk-tissue analyses. We expect scMRdb to serve as a user-friendly portal for generating cell-type-informed mechanistic hypotheses and prioritizing actionable therapeutic targets for complex human diseases.
Autor:innen und Institutionen
- China National Center for Bioinformation, Beijing 100101, China.
- Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing 100101, China.
- College of Life Sciences, University of Chinese Academy of Sciences, Beijing 101408, China.
- Beijing Key Laboratory of Intelligent Governance and Application of Biological Big Data, China National Center for Bioinformation, Beijing 100101, China.
ORCID-Profile: Peilin Jia
Förderung
- the National Science and Technology Major Project
- Strategic Priority Research Program of the Chinese Academy of Sciences
- National Natural Science Foundation of China
Zitieren
APA
Pan, S., Wang, Z., & Jia, P. (2026). scMRdb: a comprehensive resource for cell-type-resolved Mendelian randomization of complex traits. Nucleic Acids Research. https://doi.org/10.1093/nar/gkag1063
Vancouver
Pan S, Wang Z, Jia P. scMRdb: a comprehensive resource for cell-type-resolved Mendelian randomization of complex traits. Nucleic Acids Research. 2026. doi:10.1093/nar/gkag1063
BibTeX
@article{Pan2026,
author = {Pan, Siyu and Wang, Ziyang and Jia, Peilin},
title = {scMRdb: a comprehensive resource for cell-type-resolved Mendelian randomization of complex traits},
journal = {Nucleic Acids Research},
year = {2026},
doi = {10.1093/nar/gkag1063}
}
EUVIMED